From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications

SM Hattangadi, P Wong, L Zhang… - Blood, The Journal …, 2011 - ashpublications.org
This article reviews the regulation of production of RBCs at several levels. We focus on the
regulated expansion of burst-forming unit-erythroid erythroid progenitors by glucocorticoids …

[HTML][HTML] Regulation of Bim in health and disease

RV Sionov, SA Vlahopoulos, Z Granot - Oncotarget, 2015 - ncbi.nlm.nih.gov
The BH3-only Bim protein is a major determinant for initiating the intrinsic apoptotic pathway
under both physiological and pathophysiological conditions. Tight regulation of its …

Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin

T Masuda, X Wang, M Maeda, MC Canver, F Sher… - Science, 2016 - science.org
Genes encoding human β-type globin undergo a developmental switch from embryonic to
fetal to adult-type expression. Mutations in the adult form cause inherited …

[HTML][HTML] Gene therapy for β-hemoglobinopathies

M Cavazzana, C Antoniani, A Miccio - Molecular therapy, 2017 - cell.com
β-Thalassemia and sickle cell disease (SCD) are the world's two most widely disseminated
hereditary hemoglobinopathies. β-Thalassemia originated in the Mediterranean, Middle …

Transcription factor networks in erythroid cell and megakaryocyte development

LC Doré, JD Crispino - Blood, The Journal of the American …, 2011 - ashpublications.org
Erythroid cells and megakaryocytes are derived from a common precursor, the
megakaryocyte-erythroid progenitor. Although these 2 closely related hematopoietic cell …

Wake-up sleepy gene: reactivating fetal globin for β-hemoglobinopathies

B Wienert, GE Martyn, APW Funnell, KGR Quinlan… - Trends in Genetics, 2018 - cell.com
Disorders in hemoglobin (hemoglobinopathies) were the first monogenic diseases to be
characterized and remain among the most common and best understood genetic conditions …

Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies

DS Vinjamur, DE Bauer… - British journal of …, 2018 - Wiley Online Library
The major β‐haemoglobinopathies, sickle cell disease and β‐thalassaemia, represent the
most common monogenic disorders worldwide and a steadily increasing global disease …

Base editing of the HBG promoter induces potent fetal hemoglobin expression with no detectable off-target mutations in human HSCs

W Han, HY Qiu, S Sun, ZC Fu, GQ Wang, X Qian… - Cell Stem Cell, 2023 - cell.com
Reactivating silenced γ-globin expression through the disruption of repressive regulatory
domains offers a therapeutic strategy for treating β-hemoglobinopathies. Here, we used …

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer

A Lunardi, U Ala, MT Epping, L Salmena… - Nature …, 2013 - nature.com
Here we report an integrated analysis that leverages data from treatment of genetic mouse
models of prostate cancer along with clinical data from patients to elucidate new …

ZNF410 represses fetal globin by singular control of CHD4

DS Vinjamur, Q Yao, MA Cole, C McGuckin, C Ren… - Nature …, 2021 - nature.com
Known fetal hemoglobin (HbF) silencers have potential on-target liabilities for rational β-
hemoglobinopathy therapeutic inhibition. Here, through transcription factor (TF) CRISPR …